Rutgers Cancer Institute and RWJBarnabas Health's Dr. Matthew Matasar presents during “629. Aggressive Lymphomas, Immunotherapy including Bispecific Antibodies: Overcoming Barriers in Frontline Therapy: Bispecific Antibodies for Older Adults with DLBCL” at #ASH25. https://lnkd.in/enYW6tUZ American Society of Hematology #BloodCancer #CancerResearch
